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Abstract
Background: To assess the associations of biomarkers of intestinal barrier function and other clinical variables with
acute gastrointestinal injury (AGI) grade, and of these clinical variables with mortality in critically ill patients.
Methods: This was a single-center, observational, prospective study. Patients were included if they were diagnosed
with AGI and underwent tests for the measurement of plasma levels of intestinal fatty acid–binding protein (i-FABP)
, D-lactate (D-la), and lipopolysaccharide. General characteristics, AGI grades, Acute Physiology and Chronic Health
Evaluation (APACHE) II scores, Sepsis-related Organ Failure Assessment (SOFA) scores, intra-abdominal pressure (IAP),
and 28-day mortality were recorded and compared among patients with different AGI grades.
Results: Among the 90 included patients, the APACHE II score, IAP, and LPS and D-la levels significantly differed
between the four AGI grades. Multinomial logistic regression analysis with grade I as the reference for grades II, III,
and IV revealed that high APACHE II scores increased the odds of AGI grade III (odds ratio [OR], 1.754; 95%
confidence interval [CI], 1.225–2.511) and grade IV (OR, 1.493; 95% CI, 1.079–2.066). Similarly, IAP increased the
odds of AGI grade III (OR, 1.622; 95% CI, 1.111–2.369) and grade IV (OR, 1.518; 95% CI, 1.066–2.162). Elevated
D-la increased the odds of AGI grades II (OR, 1.059; 95% CI, 1.005–1.117), III (OR, 1.155; 95% CI, 1.052–2.268), and IV (OR,
1.088; 95% CI, 1.013–1.168). In contrast, i-FABP and LPS did not increase the odds of any AGI grade. SOFA scores could
independently predict the odds of death in AGI patients (OR, 1.223; 95% CI, 1.007–1.485).
Conclusion: AGI patients exhibit loss of gastrointestinal barrier function, and D-la could serve as a better marker of AGI
grade than i-FABP or lipopolysaccharide.
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Background
In critically ill patients, the intestine is a vulnerable
organ, and gastrointestinal (GI) dysfunction is common
[1]. Conversely, GI dysfunction can indicate a critical
condition. It has been reported that almost 50% of
patients in intensive care units (ICUs) have enterocyte
damage at admission [2]. Among critically ill patients,
those with GI dysfunction have higher mortality rates
than those without GI dysfunction. [3, 4]. It is therefore
important to monitor the status of the GI tract in
critically ill patients.
In 2012, the Working Group on Abdominal Problems
of the European Society of Intensive Care Medicine
(ESICM) defined acute gastrointestinal injury (AGI) as
the malfunctioning of the GI tract in critically ill patients
due to their acute illness, and recommended a four-
grade classification for AGI severity [5]. However, this
definition mainly depends on the symptoms and signs of
AGI, which are usually not sufficient to diagnose the
underlying disease [6]. Some biomarkers, for example,
blood intestinal fatty acid–binding protein (i-FABP),
D-lactate (D-la), and lipopolysaccharide (LPS), have been
proposed as possible markers for intestinal barrier func-
tion and the detection of AGI [7]. However, their clinical
validity in the diagnosis and classification of AGI is still
unclear. To our knowledge, no study has evaluated these
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biomarkers in critically ill patients with varying grades of
AGI severity.
The purpose of this study was to determine whether
biomarkers of GI barrier function could be used to indi-
cate the severity and prognosis of AGI in critically ill
patients. To this end, we assessed the association of
various clinical parameters and biomarkers of GI barrier




This prospective, observational study was conducted to
assess the correlation of certain biomarkers in critically
ill patients with different AGI grades. This study was
performed in a 25-bed general ICU at the First Hospital
of Jilin University (Changchun, China) from January 1,
2014 to June 30, 2014.
Patient selection and grouping
Patients were included if they had been hospitalized
for at least 72 h before being diagnosed with AGI, ac-
cording to the ESICM definition [5]. Patients were
excluded from the study if they were less than
18 years old; diagnosed with a malignancy, Crohn dis-
ease, ulcerative colitis, or short bowel syndrome; or
hospitalized for less than 72 h before the AGI diagno-
sis was established.
The patients were divided into four groups based on
the ESICM-recommended four-grade classification
(grades I, II, III, and IV), which in turn is based on the
calorie amount of enteral nutrition and intra-abdominal
pressure (IAP) (Table 1) [5].
Data collection and clinical evaluation
Nutritional support and other treatments were provided
according to local practice guidelines and the clinicians’
discretion. Blood samples to detect GI injury were
collected on the day the patient was diagnosed with
AGI. The samples were centrifuged, and the plasma thus
obtained was frozen at −20 °C and sent to the laboratory
within 1 week for analysis. Plasma i-FABP, D-la, and LPS
levels were measured using enzyme-linked immunosorb-
ent assay kits (R&D Systems, Minneapolis, USA). We
recruited 50 healthy volunteers and measured their
plasma i-FABP, D-la, and LPS levels as a reference.
The following data were acquired from the patients:
general characteristics, AGI grade, IAP (highest value
obtained on bladder manometry in the first 3 days,
with each measurement being performed at a set time
of the day; measurements were performed at least 4
times a day, if the IAP exceeded 12 mm Hg, and
mean values were used [3]), abdominal perfusion
pressure (APP; difference between mean blood pres-
sure and IAP, determined at the time of IAP meas-
urement), Acute Physiology and Chronic Health
Evaluation (APACHE) II score (in the first 24 h after
ICU admission), Sepsis-related Organ Failure Assess-
ment (SOFA) score (in the first 24 h after ICU ad-
mission), and 28-day mortality.
Statistical analyses
Categorical variables are presented as percentages,
whereas continuous variables are presented as median
and interquartile range (IQR). Variables involved in
the four-grade AGI classification were compared
using the Kruskal–Wallis test. Variables that were
Table 1 Classification of AGI [5]
Grade Definition
I (risk of GI dysfunction or failure) Partial impairment of GI function, manifested as gastrointestinal symptoms related to a known cause
and perceived to be transient. Examples: postoperative nausea and/or vomiting during the first few
days after abdominal surgery, postoperative absence of bowel sounds, diminished bowel motility in
the early phase of shock.
II (GI dysfunction) The GI tract is unable to perform digestion and absorption adequately to satisfy the nutrient and fluid
requirements of the body. There are no changes in the general condition of the patient due to GI
problems. Examples: gastroparesis with high gastric residuals or reflux, paralysis of the lower GI tract,
diarrhea, intra-abdominal pressure (IAP) 12–15 mmHg, visible blood in gastric content or stool. Feeding
intolerance is present if at least 20 kcal/kg BW/day via the enteral route cannot be achieved within 72 h
of a feeding attempt.
III (GI failure) Loss of GI function. Restoration of GI function is not achieved despite interventions, and the general
condition is not improving. Examples: persistent feeding intolerance despite treatment manifested as
high gastric residuals, persistent GI paralysis, occurrence or worsening of bowel dilatation, IAP,
15–20 mmHg, low abdominal perfusion pressure (below 60 mmHg). Feeding intolerance is present
and possibly associated with persistence or worsening of multiple organ dysfunction syndrome.
IV (GI failure with severe impact on
distant organ function)
AGI has progressed to become directly and immediately life-threatening, with worsening of multiple
organ dysfunction syndrome and shock. Examples: bowel ischemia with necrosis, GI bleeding leading
to hemorrhagic shock, Ogilvie syndrome, abdominal compartment syndrome requiring decompression.
Primary AGI is associated with primary disease or direct injury to organs of the GI system, such as peritonitis, pancreatitis, abdominal surgery. Secondary AGI
develops as a consequence of the host response to critical illness without a primary pathology in the GI system, such as GI malfunction in a patient with
pneumonia or non-abdominal surgery
AGI acute gastrointestinal injury, BW body weight, GI gastrointestinal, IAP intra-abdominal pressure
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statistically significant (p < 0.05) were included in the
multinomial multiple logistic regression analysis
(method: enter) to identify associations between AGI
grade and specific parameters. These variables were
also included in the ordinal logistic regression analysis
with AGI grades as the dependent variable to identify
associations between ranked AGI grade and specific
parameters. The associations between APACHE II
score, SOFA score, AGI grade, IAP, APP, mortality,
and LPS, D-la, and i-FABP levels were assessed using
univariate analysis and multiple logistic regression
analysis (method: enter).
A p-value of <0.05 was considered statistically
significant. All tests were two-sided. Data were an-
alyzed using commercially available software




Of the 245 patients initially enrolled in the study, 49
were excluded due to lack of complete information,
loss to follow-up, or an unclear AGI classification; 71
patients did not provide consent; 10 had inadequate
blood samples; and 25 were excluded due to other
reasons such as problems with operational approaches
and safekeeping. Thus, a total of 90 patients (grade I,
20 patients; grade II, 46 patients; grade III, 15
patients, and grade IV, 9 patients) were included in
the analysis (Fig. 1).
Baseline characteristics of the patients
Among the 90 included patients, the median age was
66 years (IQR, 47.0–80.0 years), the median APACHE II
score was 20.0 (IQR, 16.0–22.0), the median SOFA score
Fig. 1 Flow chart of patient selection
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was 6.0 (IQR, 4.0–9.0), and the 28-d mortality was 14
(15.6%; Table 2).
Association between AGI grade and patient
characteristics
The median IAP and APP values were 13.0 mm Hg
(IQR, 9.0–14.0 mm Hg) and 77.0 mm Hg (IQR, 63.0–
90.0 mm Hg), respectively. The median plasma i-FABP,
LPS, and D-la concentrations were 551.6 pg/mL (IQR,
438.9–660.0 pg/mL), 5.9 pg/mL (IQR, 3.9–7.7 pg/mL),
and 31.2 μmol/L (IQR, 16.1–59.7 μmol/L), respectively
(Table 3). All of these concentrations were higher than
the corresponding reference values (Table 4).
The APACHE II score, IAP, and LPS and D-la levels
significantly differed among patients with grade I, II, III,
and IV AGI (Tables 2 and 3). Multinomial logistic re-
gression analysis with grade I as the reference for grades
II, III, and IV revealed that high APACHE II score in-
creased the odds of AGI grades III (odds ratio [OR],
1.754; 95% confidence interval [CI], 1.225–2.511) and IV
(OR, 1.493; 95% CI, 1.079–2.066). Similarly, IAP
increased the odds of grade III (OR, 1.622; 95% CI,
1.111–2.369) and grade IV AGI (OR, 1.518; 95% CI, 1.066–
2.162). Elevated D-la increased the odds of AGI grade II
(OR, 1.059; 95% CI, 1.005–1.117), grade III (OR, 1.155; 95%
CI, 1.052–2.268), and grade IV (OR, 1.088; 95% CI, 1.013–
1.168). In contrast, i-FABP and LPS did not increase the
odds of any AGI grade (Table 5). Ordinal logistic regression
analysis revealed that APACHE II score (OR, 1.115; 95% CI,
1.106–1.222), IAP (OR, 1.143; 95% CI, 1.031–2.267), and
D-la (OR, 1.043; 95% CI, 1.013–1.074) were independently
associated with ranked AGI grades (Table 6).
Association of AGI-related clinical variables with 28-day
mortality
A regression analysis was conducted to determine the
association of various clinical variables with 28-d mortality
(Table 7). Univariate regression analysis showed that
higher APACHE II score, SOFA score, and AGI grade
significantly increased the odds of death in AGI patients.
In the multiple regression analysis, however, only the
SOFA score could independently predict the odds of death
in AGI patients (OR, 1.223; 95% CI, 1.007–1.485).
Discussion
This study analyzed the association of certain markers of
GI barrier function with AGI severity and mortality in
critically ill patients. The results showed that the












Age (yr) 66 (48–78) 68 (47–82) 74 (43–87) 69 (61–81) 66.0 (47.0–80.0) 0.959
Males 14 (70%) 34 (73.9%) 14 (93.3%) 7 (77.8%) 69 (76.7%) 0.393
APACHE II score 20.0 (16.5–22.0) 18.0 (11.8–22.0) 20.0 (18.0–30.0) 23.0 (18.0–28.5) 20.0 (16.0–22.0) 0.031a
SOFA score 6.0 (3.0–8.0) 5.0 (4.0–9.0) 6.0 (4.0–13.0) 8.0 (4.5–11.5) 6.0 (4.0–9.0) 0.486
Gastrointestinal surgery 1 (20%) 5 (10.9%) 1 (6.7%) 1 (11.1%) 8 (8.9%) 0.262
Primary AGI 3 (15%) 17 (37%) 5 (33.3%) 5 (55.6%) 30 (33.3%) 0.155
Sepsis 8 (40%) 19 (41.3%) 4 (26.7%) 4 (44.4%) 35 (38.9%) 0.760
Catecholamine support 5 (25%) 8 (17.4%) 5 (33.3%) 5 (55.6%) 23 (25.6%) 0.099
Mechanical ventilation 17 (85%) 34 (73.9%) 11 (73.3%) 9 (100%) 71 (78.9%) 0.281
CRRT 2 (10%) 10 (21.7%) 1 (6.7%) 1 (11.1%) 14 (15.6%) 0.421
Primary reason for intensive care 0.131
Acute pancreatitis 1 (5%) 13 (28.3%) 5 (33.3%) 1 (11.1%) 20 (22.2%)
Shock 3 (15%) 8 (17.4%) 1 (6.7%) 3 (33.3%) 15 (16.6%)
AKI 2 (10%) 10 (21.7%) 1 (6.7%) 4 (44.4%) 17 (18.9%)
ARDS 8 (40%) 14 (30.4%) 6 (40%) 5 (55.6%) 33 (36.7%)
Trauma 2 (10%) 6 (13%) 0 0 8 (8.9%)
Postoperative 3 (15%) 2 (4.3%) 2 (13.3%) 0 7 (7.8%)
Cardiac arrest 1 (5%) 1 (2.2%) 1 (6.7%) 0 3 (3.3%)
28 d-mortality 1 (5.0%) 7 (15.2%) 2 (13.3%) 4 (44.4%) 14 (15.6%) 0.067
Measurement values are expressed as median (interquartile range, 25%–75%). Categorical variables are reported as n (%). Variables were compared using the
Kruskal–Wallis test
AGI acute gastrointestinal injury, ARDS acute respiratory distress syndrome, APACHE acute physiology and chronic health evaluation, AKI acute kidney injury, CRRT
continuous renal replacement therapy, SOFA sepsis-related organ failure assessment
aSignificant differences among AGI grades I, II, III, and IV
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APACHE II score, IAP, and D-la level could reflect AGI
severity, while only the SOFA score could independently
predict the odds of death in AGI patients.
GI functions include the absorption of nutrients and
water, barrier control to modulate absorption of intra-
luminal microbes (and their products), and endocrine
and immune functions [5]. However, we currently lack
the tools or markers to comprehensively measure GI
function, and thus, we cannot reliably evaluate this in
the acute setting. Although the Recommendations of the
ESICM Working Group on Abdominal Problems de-
fined AGI and its grading, this definition is mainly based
on the functions of digestion and absorption, and does
not reflect other GI functions, such as acting as a barrier
to harmful intraluminal substances [5].
Studies have indicated that the development of mul-
tiple organ dysfunction syndrome (MODS) is associated
with a derangement in intestinal permeability that is de-
tectable before the onset of the MODS [8]. Meakins and
Marchall postulated that the gut serves as the “motor” of
MODS in injured or critically ill patients [9]. Dysfunc-
tion of the GI barrier mainly manifests as intestinal epi-
thelial hyperpermeability [10], which is common during
critical illness. Therefore, it is reasonable to suggest that
alteration of the GI barrier function plays an important
role in the development MODS or GI injury, and should
be taken into account during AGI grading.
The intestinal barrier is a protective component of the
gut, shielding us from bacterial invasion or invasion by
other microorganisms and their toxins. Intestinal perme-
ability can be understood as a measurable feature of the
intestinal barrier. Barrier function may be quantified by
measuring the translocation of bacteria or bacterial
products, such as LPS and D-la, from the gut into the
portal vein or the systemic circulation or by assaying
biomarkers of epithelial cell integrity such as i-FABP.
Few studies have investigated the role of intestinal bar-
rier function in AGI grading. We selected three biomar-
kers—LPS, D-la, and i-FABP—that reflect intestinal
permeability to evaluate intestinal barrier function [10].
LPS is a glycolipid present in the outer membrane of
gram-negative bacterial cell walls [11]. The mucosal epi-
thelium of the gastrointestinal tract serves as a major
barrier to LPS, whereas the bacteria present in the intes-
tinal lumen act as a major source of LPS [12, 13]. The
process of LPS translocation from the gastrointestinal
Table 4 Reference values of plasma i-FABP, LPS, and D-la in
healthy individuals
Biomarker Median (IQR, 25%–75%)
i-FABP (pg/mL) 31.32 (24.54–34.87)
LPS (pg/mL) 2.65 (1.17–3.45)
D-la (μmol/L) 8.21 (3.23–10.37)
Values were obtained from 50 volunteers (men, 40%) with a mean age of 47 ±
15 years. The volunteers were recruited from communities in Changchun, and
were adults without any history of malignancy, infections, or gastrointestinal
disease in the last 3 months
D-la D-lactate, i-FABP intestinal fatty acid–binding protein, IQR interquartile
range, LPS lipopolysaccharide







































































































Measurement values are expressed as median (interquartile range, 25%–75%). Categorical variables are reported as n (%). Variables were compared using the
Kruskal–Wallis test
AGI acute gastrointestinal injury, APP abdominal perfusion pressure, CRP C-reactive protein, D-la D-lactate, IAP intra-abdominal pressure, i-FABP intestinal
fatty acid–binding protein, LPS lipopolysaccharide, PCT procalcitonin
aSignificant differences among AGI grades I, II, III, and IV
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lumen to the systemic circulation is not fully under-
stood, but it is thought that the GI tract is rendered per-
meable to LPS through changes in tight junctions [14].
Hence, an increased serum level of LPS can reflect GI
barrier dysfunction and increased intestinal permeability.
This study found that the LPS level could distinguish be-
tween the different AGI grades on univariate analysis,
but not on multiple regression analysis, possibly due to
the influence of sepsis. Increased peripheral blood LPS
levels have been detected in sepsis [15], and in the
present study, a high proportion (about 40%) of the en-
rolled patients had sepsis, which could have interfered in
the relationship between blood LPS levels and AGI
grade.
Fatty acid–binding proteins are small cytosolic water-
soluble proteins present in mature enterocytes. The
levels of i-FABP have been reported to reflect the
physiological turnover rate of enterocytes, with elevated
levels indicating intestinal epithelial cell damage [16].
Thus, the i-FABP level could be a useful marker for the
early detection of significant intestinal injury [17]. The
i-FABP level has been found to correlate with the gut
dysfunction score in acute pancreatitis [18]. The present
study found that i-FABP could distinguish between
different AGI grades on univariate analysis, but not on
multiple regression analysis, which included other
factors that distinguished between AGI grades.
Normally, lactic acid exists in the form of L-lactate in
mammalian cells, which almost exclusively produce this
form of lactic acid. D-la is a fermentation product gener-
ated by many bacteria, including those present in the
human GI tract [19]. Low circulating levels of D-la are
found in healthy individuals, but in the event of intes-
tinal barrier function loss, these levels will rise as a
consequence of increased translocation across the intes-
tinal mucosa [20]. An increase in plasma D-la has been
associated with intestinal ischemia [21]. Elevated serum
D-la levels have been recorded in animals with high IAP,
and a positive correlation was detected between blood
D-la levels and IAP, and blood D-la levels may be an early
indicator of increased IAP before intestinal ischemic
changes occur [22]. A relationship between plasma D-la
and colonic permeability has been suggested [23]. How-
ever, research on D-la and GI barrier function has not
yet conclusively proven the value of this marker in evalu-
ating AGI. Moreover, increases in plasma D-la levels have
Table 5 Multiple regression analysis of characteristics of the patients divided by AGI grade
Grade II Grade III Grade IV
OR (95% CI) P OR (95% CI) P OR (95% CI) P
APACHE II score 1.017 (0.884–1.168) 0.817 1.754 (1.225–2.511) 0.002 1.493 (1.079–2.066) 0.015
IAP (mm Hg) 1.174 (0.890–1.550) 0.257 1.622 (1.111–2.369) 0.012 1.518 (1.066–2.162) 0.021
i-FABP (pg/mL) 0.993 (0.987–1.000) 0. 067 0.996 (0.985–1.007) 0. 454 0.997 (0.987–1.007) 0.575
LPS (pg/mL) 1.286 (0.846–1.956) 0.239 0.609 (0.238–1.559) 0.301 0.923 (0.497–1.714) 0.800
D-la (μmol/L) 1.059 (1.005–1.117) 0.033 1.155 (1.052–1.268) 0.003 1.088 (1.013–1.168) 0.021
Variables were compared using multinomial logistic regression for the multiple analysis; Grade I is the reference for Grades II, III, and IV
AGI acute gastrointestinal injury, APACHE acute physiology and chronic health evaluation, CI confidence interval, D-la D-lactate, IAP intra-abdominal pressure, i-FABP
intestinal fatty acid–binding protein, LPS lipopolysaccharide, OR odds ratio
Table 6 Ordinal logistic regression analysis of variables to
predict AGI grade
OR (95% CI) P
APACHE II score 1.115 (1.106–1.222) 0.021
IAP (mm Hg) 1.143 (1.031–1.267) 0.011
LPS (pg/mL) 1.077 (0.913–1.271) 0.377
D-la (μmol/L) 1.043 (1.013–1.074) 0.004
i-FABP (pg/mL) 0.997 (0.993–1.000) 0.053
AGI acute gastrointestinal injury, APACHE acute physiology and chronic health
evaluation, CI confidence interval, D-la D-lactate, IAP intra-abdominal pressure, i-FABP
intestinal fatty acid–binding protein, LPS lipopolysaccharide, OR odds ratio
Table 7 Regression analysis of variables to predict 28-day
mortality
Univariate analysis Multiple analysis
OR (95% CI) P OR (95% CI) p



































Variables were compared using binary logistic regression for the multiple
analysis; survival group is the reference for death group
AGI acute gastrointestinal injury, APACHE acute physiology and chronic health
evaluation, APP abdominal perfusion pressure, CI confidence interval; D-la, D-lactate,
IAP intra-abdominal pressure, i-FABP intestinal fatty acid–binding protein,
LPS lipopolysaccharide, OR odds ratio, SOFA sepsis-related organ
failure assessment
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been detected in other conditions with non- impaired in-
testinal barrier, such as short-bowel syndrome, due to ex-
cessive GI fermentation of carbohydrates [24]. However,
these conditions also affect GI dysfunction. Hence, we
consider that D-la is a good potential marker of GI injury
that may influence the choices of AGI therapy in critically
ill patients, and thus merits further study.
We also evaluated some clinical parameters associated
AGI, such as AGI type (primary or secondary), GI
surgery, serum albumin, sepsis, serum C-reactive pro-
tein, serum procalcitonin, arterial lactate, catecholamine
support, SOFA score, APACHE II score, and IAP. We
found APACHE II score and IAP could distinguish
between the different AGI grades on multiple regression
analysis. The finding that APACHE II scores could
distinguish between different AGI grades proves the ra-
tionality of the AGI classification [6]. Although the value
of IAP in AGI evaluation is controversial, IAP is an
important factor determining GI failure [3] and ESICM-
defined AGI. Thus, it is reasonable that IAP could
distinguish between different AGI grades.
The SOFA score, a valuable organ injury score that
has been proven to predict prognosis in critical ill
patients [25], is not based on AGI biomarkers. Thus, it
may be worthwhile to determine the association of AGI
biomarkers with SOFA scores in future studies. In this
study, we found that blood D-la levels could distinguish
AGI grades on both univariate analysis and multiple re-
gression analysis, proving that the plasma D-la level can
be a better biomarker of AGI grade than i-FABP and
LPS levels. Thus, plasma D-la levels may be helpful to
distinguish the severity of AGI and to monitor the
progression of AGI. The usefulness of this biomarker in
guiding treatment decisions and assessing therapeutic
outcomes should be assessed in future studies.
Our study has certain limitations. First, the sample size
was relatively small, and it is difficult to exclude the
effects of confounding factors due to the diverse baseline
characteristics of critically ill patients. Second, there was
no control group of critically ill patients with normal GI
function. Third, i-FABP, LPS, and D-la only partially
reflect intestinal barrier function, and tight junction
molecules such as claudins and zonula occludens [26],
were not detected in this study. Fourth, methods of
nutritional support were not included in the analysis.
Conclusions
AGI patients exhibit injury to the gastrointestinal
barrier, and D-la could serve as a better marker of
AGI grade than i-FABP or LPS. In addition to D-la,
APACHE II score and IAP were associated with AGI
grade in this study. The SOFA score was confirmed
to be useful in predicting the prognosis of critically ill
patients with AGI.
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